Phase 1 COVID-19 Longitudinal Health and Wealth - National Core Study (Phase 1 LHW-NCS)

Grant number: MC_PC_20059

Grant search

Key facts

  • Disease

    COVID-19
  • Start & end year

    2021
    2022
  • Known Financial Commitments (USD)

    $11,614,720
  • Funder

    UK Research and Innovation (UKRI)
  • Principal Investigator

    Professor Nish Chaturvedi
  • Research Location

    United Kingdom
  • Lead Research Institution

    University College London
  • Research Priority Alignment

    N/A
  • Research Category

    Policies for public health, disease control & community resilience

  • Research Subcategory

    Vaccine/Therapeutic/ treatment hesitancy

  • Special Interest Tags

    Data Management and Data Sharing

  • Study Type

    Clinical

  • Clinical Trial Details

    Not applicable

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

The Longitudinal Health and Wellbeing National Core Study will improve understanding of COVID-19 infection risk factors, examine the physical and mental health consequences of asymptomatic to hospitalised cases, and assess the impact of population scale mitigation policy. We will unite distinct, but complementary, longitudinal studies already engaged in COVID-19 research, including UK representative population and hospitalised cohorts, household panel surveys, and national primary care registries. These will be enriched with health and administrative data linkage. Linkage, self-reporting and repeat serological assessment will allow greater precision in case assignment. This collective resource will be mined by a consortium of experienced analysts linked to these resources to provide rapid answers to existing and emerging priority research questions. These include physical and mental health impacts and socioeconomic adversity of those who have had COVID-19 infection, evolving impacts on health and socioeconomic inequalities, and uptake, safety and effectiveness of vaccination and determinants of responses. Our outputs will include briefing notes as well as scientific reports in order to optimise policy influence. Phase 1 funding will: 1. Establish a centralised, responsive resource linking data assets from a diverse range of longitudinal population studies with health, social and environmental records, with harmonised governance for processing and research interrogation. 2. Inform population health and social policy by providing evidence, both proactively and in response to customers, of the medium to long term consequences of infection, and of policies to control the pandemic 3. Establish a cadre of highly skilled big data scientists

Publicationslinked via Europe PMC

Last Updated:an hour ago

View all publications at Europe PMC

Impact of the COVID-19 pandemic on antidepressant prescribing with a focus on people with learning disability and autism: an interrupted time series analysis in England using OpenSAFELY-TPP.

Impact of COVID-19 pandemic on rates of congenital heart disease procedures among children: prospective cohort analyses of 26 270 procedures in 17 860 children using CVD-COVID-UK consortium record linkage data.

Associations between different measures of SARS-CoV-2 infection status and subsequent economic inactivity: A pooled analysis of five longitudinal surveys linked to healthcare records.

Antibiotics for common infections in primary care before, during and after the COVID-19 pandemic: cohort study of extent of prescribing based on risks of infection-related hospital admissions.

COVID-19 risk by work-related factors: pooled analysis of individual linked data from 14 cohorts.

Incidence of diabetes after SARS-CoV-2 infection in England and the implications of COVID-19 vaccination: a retrospective cohort study of 16 million people.

COVID-19 diagnosis, vaccination during pregnancy, and adverse pregnancy outcomes of 865,654 women in England and Wales: a population-based cohort study.

Impact of COVID-19 on recorded blood pressure screening and hypertension management in England: an analysis of monthly changes in the quality and outcomes framework indicators in OpenSAFELY.

Cohort study of cardiovascular safety of different COVID-19 vaccination doses among 46 million adults in England.